Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).
Rigopoulos D, Tampouratzi E, Angelakopoulos C, Apalla Z, Barkis I, Georgiou S, Delli F, Drosos A, Zafiriou E, Katsantonis J, Lazaridou E, Panagakis P, Papadavid E, Papakonstantis M, Roussaki-Schulze AV, Sotiriou E, Anastasiadis G, Chasapi V, Sfaelos K, Ioannides D; BrIDGE Study Group. Rigopoulos D, et al. Among authors: sfaelos k. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):1121-1130. doi: 10.1111/jdv.19816. Epub 2024 Feb 3. J Eur Acad Dermatol Venereol. 2024. PMID: 38308561
Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study.
Rigopoulos D, Angelakopoulos C, Apalla Z, Georgiou S, Delli F, Drosos A, Zafiriou E, Katsantonis J, Lazaridou E, Panagakis P, Papadavid E, Papakonstantis M, Roussaki-Schulze AV, Sotiriou E, Anastasiadis G, Tampouratzi E, Chasapi V, Sfaelos K, Ioannides D; BrIDGE Study Group. Rigopoulos D, et al. Among authors: sfaelos k. Dermatol Ther. 2022 Dec;35(12):e15886. doi: 10.1111/dth.15886. Epub 2022 Nov 1. Dermatol Ther. 2022. PMID: 36184757
Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece.
Papadavid E, Zafeiriou E, Georgiou S, Roussaki-Schulze AV, Spiliopoulos T, Vryzaki E, Oikonomou C, Drongoula O, Boziou M, Goudouras G, Sfaelos K, Apalla Z, Lazaridou E. Papadavid E, et al. Among authors: sfaelos k. J Dermatolog Treat. 2022 Nov;33(7):3053-3059. doi: 10.1080/09546634.2022.2110836. Epub 2022 Aug 23. J Dermatolog Treat. 2022. PMID: 36000186
13 results